A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism-Reference-Cited by-同舟云学术

A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism

Author:

Hunfeld N. G.¹,Touw D. J.¹,Mathot R. A.²,Schaik R. H.³,Kuipers E. J.

Affiliation:

1. Department of Hospital Pharmacy, Central Hospital Pharmacy; Haga Teaching Hospital; Den Haag; The Netherlands

2. Department of Hospital Pharmacy; Erasmus MC - University Medical Center; Rotterdam; The Netherlands

3. Department of Hospital Clinical Chemistry; Erasmus MC - University Medical Center; Rotterdam; The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

Reference45 articles.

2. Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers;Baisley;Gut,2002

4. Esomeprazole 40 mg provides more effective acid control than standard doses of all other proton-pump inhibitors;Rohss;Gastroenterology,2001

5. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents;Robinson;Eur J Gastroenterol Hepatol,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献